A weekly trade journal catering to the Indian chemical industry
backBack

calendar 20 August, 2024 16:14:30 IST

Evonik using Knauer’s expertise to improve scale up of lipid nanoparticles formulations

Article image

Evonik is collaborating with Knauer Wissenschaftliche Geräte GmbH, a German manufacturer of scientific instruments, to improve the upscaling of lipid nanoparticle (LNP) formulations.

“By combining Evonik’s formulation and scale-up expertise with Knauer’s technological know-how, customers can improve efficiency and increase speed to market, significantly cutting the initial pre-clinical development time,” Evonik said in a press note.

“Our extensive expertise in chemistry and formulation science has enabled us to capture a significant proportion of the growing market for mRNA and gene therapies. Thanks to our collaboration with Knauer, we are now even better positioned to offer differentiation options,” said Mr. Yann d’Hervé, head of the Health Care business line at Evonik.

Nucleic acid therapeutics represent a huge and expanding proportion of the overall parental drugs market. Evonik supplies pharmaceutical companies worldwide with lipids and LNP drug product development activities. The LNP market alone is estimated to be over $600-mn (up to $1-bn) with continued growth projected over the next decade.

“Together with Knauer, we can increase the speed with which we go from very small-scale prototypes to production-scale lead formulations, and then directly into GMP production of drug products,” said Ms. Andrea Engel, head of Growth Projects Evonik Health Care.

Knauer is known for its high-end scientific instruments used in research and commercial applications. Recently, Evonik implemented Knauer’s IJM NanoScaler Pro technology, which addresses the long-standing challenges in nucleic acid LNP formulations by reducing the need for labour-intensive and time-consuming experiments, thereby significantly reducing the time and material costs associated with screening for optimal LNP formulations on platforms that do not necessarily upscale when introduced into more proven IJM large scale systems.

Lipids are the building blocks of living cells and are essential for the efficient encapsulation and delivery of mRNA and other nucleic acid-based drugs. The nucleic acids are encased in an LNP composed of specific lipids, which not only protects the nucleic acid from degradation, but also ensures its safe delivery into cells where it can be released. LNPs have emerged as the most advanced drug delivery system, highlighted by their role in the global fight against Covid-19.

article image
calender image

calender image 9 November, 2026 20:19:59 IST

Will India’s butadiene paradox resolve through integrated C4 value chain development?

India is at an important turning point in the development of its butadiene value chain. For years, the country...
article image

calender image 9 November, 2026 19:59:03 IST

GAIL subsidiary commissions PTA plant at Mangalore

GAIL (India) Ltd. has commissioned a 1.25-mtpa purified terephthalic acid (PTA) plant at the Mangalore Special Economic Zone...

PRINT EDITION

View Past Issues

Search For

Exhibitions & Conferences

ChemExpo IndiaChemProTechChemLogistics India

Watch

KKBangEchemiAPi ChinaGPCA ForumCPHI PMEC INDIA